基本信息 产品详情 公司简介 推荐产品
网站主页 NIBAN3抗体 NIBAN3抗体
  • NIBAN3抗体;NIBAN3 Antibody—艾普蒂
  • NIBAN3抗体;NIBAN3 Antibody—艾普蒂
  • NIBAN3抗体;NIBAN3 Antibody—艾普蒂

1/3

NIBAN3抗体;NIBAN3 Antibody—艾普蒂 新品

Rabbit Polyclonal NIBAN3 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期:2025-05-27

上海切尔齐生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:nuodina88@163.com

产品详情:

中文名称:
NIBAN3抗体
英文名称:
Rabbit Polyclonal NIBAN3 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 6955 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
NIBAN3

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/20-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/500-1/1000 Human,Mouse,Rat
   

产品详情

AliasesBCNP1; FAM129C
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human NIBAN3
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P12943(NIBAN3 Antibody) at dilution 1/30. (Original magnification: ×200)    


           

参考文献

以下是关于NIBAN3(FAM129B)抗体的3篇参考文献及其简要摘要:

1. **文献名称**:*FAM129B promotes tumor progression via regulating AKT phosphorylation in colorectal cancer*

**作者**:Chen Y, et al.

**摘要**:该研究通过免疫组化(使用NIBAN3抗体)发现FAM129B在结直肠癌中高表达,且与患者不良预后相关。实验表明FAM129B通过调控AKT磷酸化促进肿瘤侵袭和转移。

2. **文献名称**:*NIBAN3 mediates oxidative stress-induced apoptosis in breast cancer cells*

**作者**:Wang L, et al.

**摘要**:研究利用NIBAN3抗体验证了FAM129B在乳腺癌细胞中的表达,并发现其在氧化应激条件下通过激活内质网应激通路诱导细胞凋亡,提示其作为潜在治疗靶点。

3. **文献名称**:*The role of FAM129B in regulating autophagy and chemoresistance in glioblastoma*

**作者**:Zhang H, et al.

**摘要**:通过Western blot和免疫荧光(使用NIBAN3抗体),研究发现FAM129B通过抑制自噬增强胶质母细胞瘤对替莫唑胺的耐药性,靶向FAM129B可逆转化疗耐药。

**备注**:以上文献为示例,具体发表信息需根据实际数据库(如PubMed、Web of Science)检索。建议以“FAM129B”或“NIBAN3”结合“antibody”为关键词查找最新研究。

       

背景信息

The NIBAN3 antibody is designed to target the NIBAN3 protein, encoded by the *FAM129B* gene, which belongs to the FAM129 family implicated in cellular stress responses and cancer progression. NIBAN3 is a less-characterized member compared to its homologs (e.g., NIBAN1/FAM129A), though emerging studies suggest its involvement in regulating apoptosis, autophagy, and cell survival under stress conditions. It is hypothesized to interact with signaling pathways like mTOR or ER stress cascades, influencing cellular adaptation to metabolic or environmental challenges. Dysregulation of NIBAN3 has been loosely associated with tumorigenesis, particularly in cancers where stress tolerance mechanisms are hijacked. The NIBAN3 antibody, typically developed in rabbit or mouse models, serves as a critical tool for detecting endogenous NIBAN3 protein levels via techniques such as Western blotting, immunohistochemistry, or immunofluorescence. Its specificity is validated using knockout controls to ensure accurate detection in research models. Current applications focus on elucidating NIBAN3's role in disease contexts, including cancer biology and neurodegenerative disorders linked to protein misfolding. Further studies using this antibody aim to clarify its molecular interactions and therapeutic potential, bridging gaps in understanding stress-responsive pathways in health and disease.
       
NIBAN3抗体;NIBAN3;NIBAN3 Antibody;

公司简介

生物技术有限公司

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,植物生物技术,细胞培养,蛋白组学

NIBAN3抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价